Ocugen, Inc. (OCGN)

1.99 +0.06 (+3.11%) USD  |  NASDAQ  |  Apr 17, 16:00
1.94 -0.05 (-2.51%) After-Hours: 05:21
More

Ocugen SG&A Expense (Quarterly) : 6.132M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for OCGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
REGENXBIO, Inc. 22.38M
Krystal Biotech, Inc. 41.45M
Phathom Pharmaceuticals, Inc. 48.37M
Catalyst Pharmaceuticals, Inc. 48.23M
MannKind Corp. 58.41M